Search

everythinglearnresearchcommunity

for

Search:↓

Older patients sticking to their prostate medication saw lasting health benefits.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Taking dutasteride every other day works as well as daily and better preserves sexual function.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Finasteride may affect PNMT, causing side effects.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

P-3074 effectively blocks scalp DHT better than oral finasteride.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.

Dutasteride helps hair growth in those unresponsive to finasteride, but may cause more sexual dysfunction.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Bicalutamide improves hair density in women safely.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Dutasteride effectively treats hair loss and prostate issues.

Finasteride and dutasteride are equally effective and safe for treating BPH.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Men with better urinary symptoms have a lower risk of death.